Concord Medical Services (CCM) Competitors $4.35 -0.15 (-3.33%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends CCM vs. PIII, XGN, ENZ, BNR, MRAI, OPGN, PMD, TOI, BRTX, and ATIPShould you be buying Concord Medical Services stock or one of its competitors? The main competitors of Concord Medical Services include P3 Health Partners (PIII), Exagen (XGN), Enzo Biochem (ENZ), Burning Rock Biotech (BNR), Marpai (MRAI), OpGen (OPGN), Psychemedics (PMD), Oncology Institute (TOI), BioRestorative Therapies (BRTX), and ATI Physical Therapy (ATIP). These companies are all part of the "healthcare" industry. Concord Medical Services vs. P3 Health Partners Exagen Enzo Biochem Burning Rock Biotech Marpai OpGen Psychemedics Oncology Institute BioRestorative Therapies ATI Physical Therapy P3 Health Partners (NASDAQ:PIII) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations, community ranking, institutional ownership and media sentiment. Do institutionals and insiders hold more shares of PIII or CCM? 7.8% of P3 Health Partners shares are owned by institutional investors. 17.9% of P3 Health Partners shares are owned by company insiders. Comparatively, 46.5% of Concord Medical Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more risk & volatility, PIII or CCM? P3 Health Partners has a beta of 1.15, suggesting that its stock price is 15% more volatile than the S&P 500. Comparatively, Concord Medical Services has a beta of -0.27, suggesting that its stock price is 127% less volatile than the S&P 500. Does the media prefer PIII or CCM? In the previous week, P3 Health Partners had 6 more articles in the media than Concord Medical Services. MarketBeat recorded 7 mentions for P3 Health Partners and 1 mentions for Concord Medical Services. Concord Medical Services' average media sentiment score of 0.00 beat P3 Health Partners' score of -0.49 indicating that Concord Medical Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment P3 Health Partners 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Concord Medical Services 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community believe in PIII or CCM? Concord Medical Services received 193 more outperform votes than P3 Health Partners when rated by MarketBeat users. Likewise, 62.54% of users gave Concord Medical Services an outperform vote while only 26.67% of users gave P3 Health Partners an outperform vote. CompanyUnderperformOutperformP3 Health PartnersOutperform Votes426.67% Underperform Votes1173.33% Concord Medical ServicesOutperform Votes19762.54% Underperform Votes11837.46% Do analysts rate PIII or CCM? P3 Health Partners presently has a consensus price target of $2.38, indicating a potential upside of 1,065.36%. Given P3 Health Partners' stronger consensus rating and higher possible upside, equities research analysts clearly believe P3 Health Partners is more favorable than Concord Medical Services.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score P3 Health Partners 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50Concord Medical Services 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is PIII or CCM more profitable? Concord Medical Services has a net margin of 0.00% compared to P3 Health Partners' net margin of -6.95%. Concord Medical Services' return on equity of 0.00% beat P3 Health Partners' return on equity.Company Net Margins Return on Equity Return on Assets P3 Health Partners-6.95% -71.31% -11.93% Concord Medical Services N/A N/A N/A Which has higher earnings & valuation, PIII or CCM? Concord Medical Services has lower revenue, but higher earnings than P3 Health Partners. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioP3 Health Partners$1.27B0.06-$57.77M-$0.84-0.24Concord Medical Services$75.69M0.25-$41.93MN/AN/A SummaryConcord Medical Services beats P3 Health Partners on 9 of the 16 factors compared between the two stocks. Ad DarwinNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! Get Concord Medical Services News Delivered to You Automatically Sign up to receive the latest news and ratings for CCM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CCM vs. The Competition Export to ExcelMetricConcord Medical ServicesOffices & clinics of medical doctors IndustryMedical SectorNYSE ExchangeMarket Cap$19.54M$952.61M$5.07B$19.96BDividend YieldN/AN/A4.99%3.49%P/E RatioN/A5.5187.8636.42Price / Sales0.251.371,228.8217.94Price / CashN/A43.0439.5121.28Price / Book0.082.966.944.59Net Income-$41.93M-$52.07M$119.12M$985.93M7 Day Performance-14.34%-9.44%-1.84%0.45%1 Month Performance-44.94%-11.03%-3.65%1.05%1 Year Performance-60.59%-13.01%31.64%24.67% Concord Medical Services Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CCMConcord Medical Services0.3453 of 5 stars$4.35-3.3%N/A-58.6%$19.54M$75.69M0.00970Gap UpPIIIP3 Health Partners3.2506 of 5 stars$0.20-4.7%$2.38+1,065.4%-82.9%$75.44M$1.27B0.00500Analyst ForecastAnalyst RevisionHigh Trading VolumeXGNExagen4.7894 of 5 stars$4.20+19.0%$7.00+66.7%+169.2%$62.26M$52.55M0.00220Analyst RevisionGap UpHigh Trading VolumeENZEnzo Biochem0.5158 of 5 stars$0.99-2.0%N/A-22.3%$52.77M$31.91M0.00520BNRBurning Rock BiotechN/A$4.64+0.9%N/A-48.5%$47.12M$75.70M0.001,390MRAIMarpai2.0113 of 5 stars$1.64+13.1%$6.00+265.9%+80.2%$19.92M$37.15M-0.62150OPGNOpGenN/A$1.99+1.5%N/A-55.8%$16.40M$3.42M0.00100News CoveragePMDPsychemedics0.5329 of 5 stars$2.33-0.4%N/A+11.0%$13.79M$22.10M-4.57140TOIOncology Institute2.3174 of 5 stars$0.13-27.4%$2.50+1,791.1%-94.1%$13.59M$324.24M0.00660Gap DownHigh Trading VolumeBRTXBioRestorative Therapies3.7191 of 5 stars$1.40+0.7%$18.00+1,185.7%-22.2%$9.62M$150,000.00-0.927Analyst RevisionNews CoverageGap UpATIPATI Physical Therapy0.224 of 5 stars$1.59-7.6%N/A-78.2%$7.59M$699.02M0.005,600 Related Companies and Tools Related Companies PIII Alternatives XGN Alternatives ENZ Alternatives BNR Alternatives MRAI Alternatives OPGN Alternatives PMD Alternatives TOI Alternatives BRTX Alternatives ATIP Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:CCM) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Concord Medical Services Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Concord Medical Services With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
